Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Reexamination Certificate
2007-12-18
2007-12-18
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
C435S005000, C435S006120, C435S007100, C424S184100, C424S204100, C424S229100, C530S300000, C530S350000
Reexamination Certificate
active
10673017
ABSTRACT:
This invention relates to Equine Herpes Viruses (EHV) wherein the protein gM is essentially absent or modified and non-functional with respect to its immunomodulatory capacity. Further aspects of the invention relate to nucleic acids coding said viruses, pharmaceutical compositions comprising these viruses or nucleic acids and uses thereof. The invention also relates to methods for improving the immune response induced by an EHV vaccine against wild type EHV infections, methods for the prophylaxis and treatment of EHV infections and methods for distinguishing wild type EHV infected animals from animals treated with EHV's according to the invention.
REFERENCES:
patent: 5922327 (1999-07-01), Crabb et al.
Neubauer et al., Equine Herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection, Virology, 1997, vol. 239, pp. 36-45.
Osterrieder et al., Synthesis and processing of the Equine Herpesvirus 1 glycoprotein M, Virology, 1997, vol. 232, pp. 230-239.
Osterrieder et al., The Equine Herpesvirus 1 glycoprotein gp21/22a, the Herpes Simplex Virus type 1 gM homolog, is involved in virus penetration and cell-to-cell spread of virions, Journal of Virology, Jun. 1996, vol. 70, No. 6, pp. 4110-4115.
Neubauer, A. et al: “Equine herpesvirus 1 mutants devoid of glycorprotein B or M are apathogenic for mice but induce protection against challenge infection.”, Virology (Dec. 1997), 239(1):36-45.
Osterrieder, N. et al: The Equine Herpesvirus 1 Glycoprotein gp21/22a, the Herpes Simplex Virus Type 1 gM Homolog, is involved in Virus Penetration and Cell-to Cell Spread of Virions, J. of Virol., 70(6):4110-4115, Jun. 1996.
Seyboldt, C. et al: “Equine herpesvirus 1 (EHV-1) glycoprotein M: Effect of deletions of transmembrane domains”; Virology, (Dec. 2000) 278 (2):477-489.
Osterrieder, et al; Deletion of gene 52 encoding glycoprotein M of equine herpesvirsu type 1 strain RacH results in increased immunogenicity; Veterinary Microbiology; vol. 81 (2001) pp. 219-226; Elsevier.
Elbers Knut
Osterrieder Nikolaus
Seyboldt Christian
Boehringer Ingelheim Vetmedica GmbH
Campell Bruce R.
Devlin Mary-Ellen
Hurt Sharon
Morris Michael P.
LandOfFree
gM-negative EHV-mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with gM-negative EHV-mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and gM-negative EHV-mutants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3854353